Read + Share
Fillbrunn M, Signorovitch J, Andre F, Wang I, et al. PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast
cancer: a meta-analysis of published clinical trials. BMC Cancer 2022;22:1002.
PMID: 36131248
|
 |
|
Fillbrunn M, Signorovitch J, Andre F, Wang I, et al. PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast
cancer: a meta-analysis of published clinical trials. BMC Cancer 2022;22:1002.
PMID: 36131248
|
|
|
|